Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U7 small nuclear 70 pseudogene (RNU7-70P) represents a pseudogene of the U7 small nuclear RNA gene family[5]. U7 small nuclear RNA (snRNA) is a functional RNA molecule central to the 3' end processing of replication-dependent histone pre-mRNAs in metazoans[2][3]. However, RNU7-70P itself is annotated as a pseudogene, meaning it is a nonfunctional copy—often transcribed but not resulting in a functional RNA or protein and typically lacking biological activity[5]. Unlike canonical U7 snRNA, which forms part of the U7 snRNP involved in histone pre-mRNA processing, the pseudogene variant does not perform demonstrated biological or therapeutic functions and is not considered a therapeutic target or biomarker[5]. Additional context: - Pseudogenes like RNU7-70P are genomic sequences similar to known genes but are generally nonfunctional due to mutations or lack of necessary regulatory context[5]. - U7 snRNA’s canonical role is specific to the maturation of histone mRNAs, not to this pseudogene[1][2][3]. - There is no evidence supporting RNU7-70P as a drug target, disease-associated locus, or functional biomolecule in cell biology or medicine[5]. Summary of key points: - RNU7-70P is a pseudogene and not a functional RNA or a therapeutic target[5]. - There are no documented molecular functions, disease roles, drug interactions, or biomarker applications for this pseudogene. - The entry may be redundant, non-canonical, or not meaningful as a therapeutic target, and should generally be excluded from structured drug target databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 70 pseudogene (RNU7-70P).